未登录

R

Robin Polt

University of Arizona

H指数:36

被引数:4,167

浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cyclic Glycopeptide Analogs of Endomorphin-1 Provide Highly Effective Antinociception in Male and Female Mice

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2024-09-170

OAAI

Structure-Based Design of Glycosylated Oxytocin Analogues with Improved Selectivity and Antinociceptive Activity

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2023-01-246

OA

PNA5, A Novel Mas Receptor Agonist, Improves Neurovascular and Blood-Brain-Barrier Function in a Mouse Model of Vascular Cognitive Impairment and Dementia

PNA5是一种新型的Mas受体激动剂，可改善血管性认知障碍和痴呆小鼠模型的神经血管和血脑屏障功能

AGING AND DISEASE

IF6.9

2023-01-012

OAAI

Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols

IF5.5

2022-09-0539

OAAI

Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release

IF5.5

2022-03-087

OAAI

Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia

神经丝光: 一种可能的预后生物标志物，用于治疗血管性对认知障碍和痴呆的影响

JOURNAL OF NEUROINFLAMMATION

IF10.1

2021-10-1512

OAAI

Angiotensin-(1-7) Peptide Hormone Reduces Inflammation and Pathogen Burden during Mycoplasma pneumoniae Infection in Mice

IF5.5

2021-10-0411

OAAI

Synthesis, Physicochemical Characterization, In Vitro 2D/3D Human Cell Culture, and In Vitro Aerosol Dispersion Performance of Advanced Spray Dried and Co-Spray Dried Angiotensin (1-7) Peptide and PNA5 with Trehalose as Microparticles/Nanoparticles for Targeted Respiratory Delivery as Dry Powder Inhalers

IF5.5

2021-08-1712

OAAI

Synthesis and In Vitro Characterization of Glycopeptide Drug Candidates Related to PACAP1-23

IF4.6

2021-08-141

OAAI

Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection

吸入给药治疗和预防新型冠状病毒肺炎感染

IF5.5

2021-07-1446

OAAI

Spray-Dried Inhalable Powder Formulations of Therapeutic Proteins and Peptides

AAPS PHARMSCITECH

IF4

2021-06-1842

PRE

Strain Differences in the Delta Opioid Receptor Agonist Properties of the Multifunctional Opioid Glycopeptide MMP2200

IF4.2

2021-05-140

PRE

Organic Solution Advanced Spray-Dried Microparticulate/Nanoparticulate Dry Powders of Lactomorphin for Respiratory Delivery: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies

IF5.5

2020-12-2515

OAAI

Characterization of Delta Opioid Receptor Activity of MMP2200, a Mixed Efficacy Mu and Delta Opioid Receptor Agonist

IF4.2

2020-04-180

OA

Behavioral pharmacology of the mixed-action delta-selective opioid receptor agonist BBI-11008: studies on acute, inflammatory and neuropathic pain, respiration, and drug self-administration

PSYCHOPHARMACOLOGY

IF3.3

2020-01-079

OAAI

A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2019-04-0158

OAAI

Biodegradability and toxicity of monorhamnolipid biosurfactant diastereomers

单鼠李糖脂生物表面活性剂非对映体的生物降解性和毒性

JOURNAL OF HAZARDOUS MATERIALS

IF11.3

2019-02-0139

OAAI

Synthesis and Characterization of Four Diastereomers of Monorhamnolipids

四种单鼠尾草脂非对映异构体的合成与表征

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2017-04-0338

PREAI

Alkyl melibioside and alkyl cellobioside surfactants: effect of sugar headgroup and alkyl chain length on performance

GREEN CHEMISTRY

IF9.2

2016-01-0117

PRE

Structural Requirements for CNS Active Opioid Glycopeptides

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2015-07-2314

PREAI